期刊文献+

高效液相色谱-质谱联用测定婴幼儿配方奶粉中的左旋肉碱 被引量:28

Determination of L-Carnitine in Infant Formula Milk Powder by Highperformance Liquid Chromatography-Mass Spectrometry
下载PDF
导出
摘要 建立了婴幼儿配方奶粉中左旋肉碱含量的高效液相色谱-质谱联用测定方法。采用C4色谱柱(4.6mm×250 mm,5μm)进行分离,以甲醇-水(10∶90)为流动相,柱温25℃,流速1.0 mL.min-1,进样量为10μL,柱后分流比为1∶3,质谱采用多离子反应监测(MRM)方式进行检测,正离子模式,定量离子为m/z 162.2→103.1。在优化条件下,样品在10 min内完成分析,左旋肉碱在0.40~10.0 mg.L-1范围内线性关系良好(r=0.999 3)。方法的加标回收率为87%~106%,检出限(S/N=3)和定量下限(S/N=10)分别为39.0、116.9 ng。该方法操作简便、灵敏度高、重复性好,可用于婴幼儿配方奶粉中左旋肉碱的测定。 A high-performance liquid chromatography -mass spectrometric method was developed for the determination of L-carnitine in infant formula milk powder. After pretreatment procedure, the sample was separated on a C4 (4.6 mm x 250 mm, 5 μm) column using methanol -water (10 : 90) as mobile phase with a flow rate of 1.0 mL · min- 1, a column temperature of 25 ℃ and injection vol- ume of 10μL. The split ratio of post column was 1 : 3. The target compound was detected under multiple reaction monitoring(MRM) mode with positive ion using m/z 162.2→103.1 as the quantita- tion ions. Each analysis was completed within 10 rain. A good linear calibration for L-carnitine was obtained in the range of 0. 40 -10.0 mg · L^-1 with a correlation coefficient of 0. 999 3. The spiked recoveries were in the range of 87% -106%. The limit of detection(S/N = 3 ) and limit of quantita- tion(S/N = 10) of L-carnitine were 39. 0 ng and 116. 9 ng, respectively. The proposed method was simple, sensitive and reproducible, and was suitable for the determination of L-carnitine in infant formula food.
出处 《分析测试学报》 CAS CSCD 北大核心 2012年第3期355-358,共4页 Journal of Instrumental Analysis
关键词 左旋肉碱 液相色谱-质谱 婴幼儿配方奶粉 L-carnitine HPLC -MS infant formula milk powder
  • 相关文献

参考文献15

二级参考文献36

  • 1周建鸿.肉碱与婴儿配方食品[J].国外医学(卫生学分册),1994,21(5):290-293. 被引量:17
  • 2高建峰,顾文秀.左旋肉碱:新型多功能营养添加剂[J].化学教学,2005(10):37-39. 被引量:7
  • 3周书凤,何志谦.左旋肉碱——一种人体特定条件下的必需营养素[J].国外医学(卫生学分册),1996,23(1):33-36. 被引量:17
  • 4周建鸿,刘冬生.强化L-肉碱对幼鼠生长和脂肪代谢的影响[J].营养学报,1996,18(2):209-212. 被引量:17
  • 5Engel AG,Franzini-Armstrong C.Myopathy[M].New York:McGraw Hill,1994:1587-1609
  • 6Lamhonwah AM,Olpin SE,Pollitt RJ,et al.Novel OCTN2 mutations:No genotype-phenotype correlations:Early carnitine therapy prevents cardiomyopathy[J].Am J Med Genet,2002,111:271-284
  • 7Takeyama N,Takagi D,Adachi K,et al.Measurement of free and esterified carnitine in tissue extracts by high performance liquid chromatography[J].Analytical Biochemistry,1986,158:346-354
  • 8Minkler PE,Hoppel CL.Quantification of free carnitine,individual shortand medium-chain acylcarnitines,and total carnitine in plasma by highperformance liquid chromatography[J].Analytical Biochemistry,1993,212:510-518
  • 9Longo A,Bruno G,Curti S,et al.Determination of L-carnitine,acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after per-column derivatization with 1-aminoanthracene[J].J Chromatography B,1996,686:129-139
  • 10Minkler PE,Ingalls ST,Kormos LS,et al.Determination of carnitine,butyrobetaine,and betaine as 4bromophenacyl ester derivatives by high-performance liquid chromatography[J].J Chromatography,1984,336:271-283

共引文献50

同被引文献233

引证文献28

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部